JP2022513043A5 - - Google Patents
Info
- Publication number
- JP2022513043A5 JP2022513043A5 JP2021526460A JP2021526460A JP2022513043A5 JP 2022513043 A5 JP2022513043 A5 JP 2022513043A5 JP 2021526460 A JP2021526460 A JP 2021526460A JP 2021526460 A JP2021526460 A JP 2021526460A JP 2022513043 A5 JP2022513043 A5 JP 2022513043A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- independently selected
- reference target
- manipulated
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024199831A JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたcd25ポリペプチドおよびその使用 |
| JP2026003911A JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたcd25ポリペプチドおよびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862767431P | 2018-11-14 | 2018-11-14 | |
| US62/767,431 | 2018-11-14 | ||
| US201962902334P | 2019-09-18 | 2019-09-18 | |
| US62/902,334 | 2019-09-18 | ||
| PCT/US2019/061567 WO2020102603A1 (en) | 2018-11-14 | 2019-11-14 | Engineered cd25 polypeptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199831A Division JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたcd25ポリペプチドおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513043A JP2022513043A (ja) | 2022-02-07 |
| JP2022513043A5 true JP2022513043A5 (cg-RX-API-DMAC7.html) | 2023-06-14 |
| JP7695881B2 JP7695881B2 (ja) | 2025-06-19 |
Family
ID=70731914
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526460A Active JP7695881B2 (ja) | 2018-11-14 | 2019-11-14 | 操作されたcd25ポリペプチドおよびその使用 |
| JP2024199831A Pending JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたcd25ポリペプチドおよびその使用 |
| JP2026003911A Pending JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたcd25ポリペプチドおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024199831A Pending JP2025026923A (ja) | 2018-11-14 | 2024-11-15 | 操作されたcd25ポリペプチドおよびその使用 |
| JP2026003911A Pending JP2026065087A (ja) | 2018-11-14 | 2026-01-13 | 操作されたcd25ポリペプチドおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12441803B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3880698A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7695881B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113646330A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3120102A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020102603A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109053882B (zh) * | 2018-08-28 | 2019-08-23 | 东莞市朋志生物科技有限公司 | 一种ns1蛋白的结合蛋白以及应用 |
| CA3120096A1 (en) | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Cd25 antibodies |
| CA3142339A1 (en) * | 2019-05-31 | 2020-12-03 | Rubryc Therapeutics, Inc. | Machine learning-based apparatus for engineering meso-scale peptides and methods and system for the same |
| US20210174909A1 (en) * | 2019-12-10 | 2021-06-10 | Homodeus, Inc. | Generative machine learning models for predicting functional protein sequences |
| JP7839789B2 (ja) * | 2020-11-10 | 2026-04-02 | ザ スクリプス リサーチ インスティテュート | オピオイド治療用抗体 |
| US20240096443A1 (en) * | 2020-12-01 | 2024-03-21 | Ibio, Inc. | Generalized Scaffolds for Polypeptide Display and Uses Thereof |
| US20250179196A1 (en) * | 2021-07-30 | 2025-06-05 | Janssen Biotech, Inc. | Materials and methods of making or using il-23r binding proteins |
| CN114384245B (zh) * | 2022-03-24 | 2022-06-24 | 江苏美克医学技术有限公司 | 新型冠状病毒s-rbd蛋白和n蛋白双表位识别的联检试剂盒及其应用 |
| WO2025235413A1 (en) * | 2024-05-05 | 2025-11-13 | Duke University | Compositions targeting cancer antigens and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279057C (zh) * | 2002-07-12 | 2006-10-11 | 马菁 | 重组的抗cd25单克隆抗体、其编码序列及应用 |
| AU2003295471B2 (en) | 2002-11-15 | 2011-08-25 | Genmab A/S | Human monoclonal antibodies against CD25 |
| CN107129524B (zh) | 2007-09-25 | 2023-11-21 | 田园温室气体研究有限公司 | 用于抑制微生物细胞的疫苗和疫苗组分 |
| WO2011051327A2 (en) | 2009-10-30 | 2011-05-05 | Novartis Ag | Small antibody-like single chain proteins |
| EA201892619A1 (ru) * | 2011-04-29 | 2019-04-30 | Роше Гликарт Аг | Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2 |
| WO2014028776A1 (en) | 2012-08-15 | 2014-02-20 | Zyngenia, Inc. | Monovalent and multivalent multispecific complexes and uses thereof |
| EP4421177A3 (en) * | 2013-03-13 | 2024-12-18 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| EP3421495A3 (en) | 2013-03-15 | 2019-05-15 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
| US20170224799A1 (en) | 2014-09-10 | 2017-08-10 | The University Of Connecticut | Identification of immunologically protective neo-epitopes for the treatment of cancers |
| US10377815B2 (en) | 2015-05-05 | 2019-08-13 | Albert Einstein College Of Medicine | Bispecific antibodies and fusion proteins that bind to EBOV and NPC1 |
| EP3538551A4 (en) * | 2016-11-10 | 2020-11-11 | Fortis Therapeutics, Inc. | CD46 SPECIFIC EFFECTOR CELLS AND USES THEREOF |
| US11879014B2 (en) | 2017-03-17 | 2024-01-23 | Tusk Therapeutics Ltd. | Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody |
| EA201900443A1 (ru) * | 2017-04-18 | 2020-03-06 | Р-Фарм Оверсиз Инк. | Антитело к pd-l1 и его применение |
| PE20210313A1 (es) * | 2018-03-28 | 2021-02-12 | Bristol Myers Squibb Co | Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso |
| CA3120096A1 (en) | 2018-11-14 | 2020-05-22 | Rubryc Therapeutics, Inc. | Cd25 antibodies |
| CA3142339A1 (en) | 2019-05-31 | 2020-12-03 | Rubryc Therapeutics, Inc. | Machine learning-based apparatus for engineering meso-scale peptides and methods and system for the same |
-
2019
- 2019-11-14 CN CN201980088633.3A patent/CN113646330A/zh active Pending
- 2019-11-14 JP JP2021526460A patent/JP7695881B2/ja active Active
- 2019-11-14 EP EP19885972.0A patent/EP3880698A4/en active Pending
- 2019-11-14 CA CA3120102A patent/CA3120102A1/en active Pending
- 2019-11-14 WO PCT/US2019/061567 patent/WO2020102603A1/en not_active Ceased
-
2021
- 2021-05-13 US US17/320,118 patent/US12441803B2/en active Active
-
2024
- 2024-11-15 JP JP2024199831A patent/JP2025026923A/ja active Pending
-
2026
- 2026-01-13 JP JP2026003911A patent/JP2026065087A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7840836B2 (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| JP7323513B2 (ja) | 抗4-1bb抗体とその作製及び使用方法 | |
| CN105849124B (zh) | 双重特异性抗体 | |
| US20210230269A1 (en) | Immune-stimulating monoclonal antibodies against human interleukin-2 | |
| JP7257971B6 (ja) | 抗cd40抗体、その抗原結合フラグメント、およびその医学的使用 | |
| JP5818804B2 (ja) | ヒトil−22raに対するヒト化抗体 | |
| NZ717476A (en) | Anti-garp protein and uses thereof | |
| RU2018146050A (ru) | Биспецифические связывающие белки, которые связывают иммуномодулирующий белок и опухолевый антиген | |
| RU2015115956A (ru) | Антитела, специфичные в отношении фактора роста тромбоцитов в, и их композиции и применения | |
| JP6949012B2 (ja) | B型肝炎表面抗原に対する抗体及びその使用 | |
| RU2011101969A (ru) | Антитела к человеческому интерлейкину-20 | |
| JP2007530551A5 (cg-RX-API-DMAC7.html) | ||
| JP2016509014A (ja) | 新規の多特異的構成物 | |
| KR20160085793A (ko) | Il-17a 접합체 및 이의 용도 | |
| JP2016521272A (ja) | インターロイキン−20に対するヒト化抗体および炎症性疾患のための治療 | |
| JP6755513B2 (ja) | 抗スクレロスチン抗体、その抗原結合フラグメントおよびその医薬用途 | |
| CN114846026A (zh) | 对人il-13和il-17具有结合特异性的多特异性抗体 | |
| JP2019518473A5 (cg-RX-API-DMAC7.html) | ||
| US12037409B2 (en) | Antibody specifically bound to glycosylated CEACAM5 | |
| WO2013186630A2 (en) | Humanized antibodies to ca215 | |
| CN120554509A (zh) | 靶向CD3e/g的抗体或其抗原结合片段、其制备和应用 | |
| CN117843784A (zh) | 抗人cd73抗体或其抗原结合片段及其应用 | |
| CN117866092A (zh) | 抗人cd73抗体或其抗原结合片段及其应用 | |
| WO2025126102A1 (en) | Enpp3 × cd3 bispecific antibodies and use thereof | |
| WO2025256628A1 (zh) | 抗adamts-7抗体及其应用 |